Is NAFLD a Risk Factor for Colorectal Polyps? An Analysis of Single Romanian Centre

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-E386.10.1002/ijc.2921025220842Search in Google Scholar

2. Tanaka T. Colorectal carcinogenesis: Review of human and experimental animal studies. J Carcinog. 2009;8:5.10.4103/1477-3163.49014267886419332896Search in Google Scholar

3. Touzin NT, Bush KN, Williams CD, Harrison SA. Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2011;4:169-176.10.1177/1756283X11402118310561221694801Search in Google Scholar

4. Tarantino G., Finelli C. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?. World J Gastroenterol. 2013;19:3375–3384.10.3748/wjg.v19.i22.3375368367523801829Search in Google Scholar

5. Williams CD, Stengel J, Asike MI, etal. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124-131.10.1053/j.gastro.2010.09.03820858492Search in Google Scholar

6. Singh SP, Singh A, Pati GK, et al - A Study of Prevalence of Diabetes and Prediabetes in Patients of Non-Alcoholic Fatty Liver Disease and the Impact of Diabetes on Liver Histology in Coastal Eastern India. Journal of Diabetes Mellitus, 2014;4:290-296.10.4236/jdm.2014.44040Search in Google Scholar

7. Wai-Sun Wong V et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut doi:10.1136/gut.2011.23797410.1136/gut.2011.23797421339204Search in Google Scholar

8. Hwang ST, Cho YK, Park JH, et al. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol. 2010;25:562-567.10.1111/j.1440-1746.2009.06117.x20074156Search in Google Scholar

9. Braun S, Bitton-Worms K, LeRoith D. The Link between the Metabolic Syndrome and Cancer. Int J Biol Sci. 2011;7:1003-1015.10.7150/ijbs.7.1003316415021912508Search in Google Scholar

10. Said O. Muhidin, Ahmed A. Magan, Khalid A. Osman, Shareef Syed, and Mohamed H. Ahmed. The Relationship between Nonalcoholic Fatty Liver Disease and Colorectal Cancer: The Future Challenges and Outcomes of theMetabolic Syndrome. J Obes. 2012:637538.10.1155/2012/637538352359023304464Search in Google Scholar

11. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F. On behalf of the Risk Factors and Life Expectancy Research Group. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev. 2001;10:937-941.Search in Google Scholar

12. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin. Liver Dis. 2007;11:37–54.10.1016/j.cld.2007.02.01417544971Search in Google Scholar